Clinical Trials Logo

Colonoscopy clinical trials

View clinical trials related to Colonoscopy.

Filter by:
  • Not yet recruiting  
  • Page 1 ·  Next »

NCT ID: NCT06208956 Not yet recruiting - Colonoscopy Clinical Trials

A Low Dose Dexmedetomidine in Sedation Colonoscopy

Start date: January 20, 2024
Phase: N/A
Study type: Interventional

104 patients who undergo painless colonoscopy from January 20,2024 to February 29,2024 will be randomized to two groups: propofol group and dexmedetomidine group. In the dexmedetomidine group,dexmedetomidine is infusion intravenously with a loading dose of 0.5 μg kg-1 for 10 min, then infusion at 0.3 μg kg-1 h-1 according to the ideal body weight of the patient until the end of colonoscopy. In the propofol group, Propofol is administrated 1 mg kg-1 intravenously, then titrated given by 0.5 mg kg-1 during the whole process.

NCT ID: NCT06192394 Not yet recruiting - Colonoscopy Clinical Trials

Gum Chewing and Abdominal Vibration: Impact on Bowel Preparation Quality and Patient Satisfaction

Start date: March 2024
Phase: N/A
Study type: Interventional

Colorectal cancers are a significant global health issue, underscoring the critical importance of screening programs for early detection and effective treatment. The success of a colonoscopy is largely contingent on the quality of bowel preparation. Inadequate bowel preparation can diminish the effectiveness of a colonoscopy and lead to the oversight of lesions. Previous research has demonstrated the positive effects of diet, education, and polyethylene glycol use on bowel preparation. However, there is limited research on the impact of methods such as gum chewing and abdominal vibration. This study aims to assess the effects of gum chewing and abdominal vibration, in addition to diet and medication, on the quality of bowel preparation and patient satisfaction in the pre-colonoscopy bowel preparation process. The study employs a randomized controlled single-blind experimental design with three distinct groups: a control group, a gum chewing group, and an abdominal vibration group. Each group will be evaluated based on bowel preparation quality and patient satisfaction. Bowel preparation quality will be determined using the Boston Bowel Preparation Scale, and factors such as polyp detection, the processability of the colonoscopy, and cecal intubation time will also be assessed. Patient satisfaction levels will be evaluated by considering how satisfied patients are with the colonoscopy process, taking into account complaints before and after the procedure. The outcomes of this study will contribute to a better understanding of the impact of gum chewing and abdominal vibration on the quality of bowel preparation and patient satisfaction before colonoscopy. Identifying effective methods to enhance bowel preparation quality can elevate the standard of nursing care, contributing to a healthier society. Simultaneously, this research can improve the comfort and efficacy of the colonoscopy process for patients and enhance the effectiveness of colorectal cancer screening programs, thereby benefiting public health.

NCT ID: NCT06094270 Not yet recruiting - Colonoscopy Clinical Trials

Artificial-intelligence-based Reporting Technology for Endoscopy Monitoring and Imaging System

ARTEMIS
Start date: January 1, 2024
Phase:
Study type: Observational

Properly documenting withdrawal time in colonoscopy is essential for quality assessment and cost allocation. However, reporting withdrawal time has significant interobserver variability. Additionally, current manual documentation of endoscopic findings is time-consuming and distracting for the physician. This trial examines an artificial intelligence based system to determine withdrawal time and create a structured report, including high-quality images (AI) of detected polyps and landmarks.

NCT ID: NCT06062030 Not yet recruiting - Colonoscopy Clinical Trials

Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;

Start date: November 2023
Phase: Phase 3
Study type: Interventional

Phase of Development : III Sponsor : DAEWOONG PHARMACEUTICAL Study Sites and Principal Investigator : Dong ll Park M.D. Ph.D , Gastroenterology Kangbuk Samsung Hospital and other 5 study sites Study Period : From the protocol approval date (institutional review board, IRB) 24 Months Investigational product : Investigational Products DWJ1609 (sodium sulfate potassium sulfate, Magnesium Sulfate Anhydrous , simethicone, sodium picosulphate) Control Products DWC202304 (sodium sulfate potassium sulfate, Magnesium Sulfate Anhydrous , simethicone) Target Diseases : A person who needs treatment before colonoscopy (X-ray, endoscopy) Number of Subjects : 214 Subjects in total (85 subjects per group, 2 groups in total, considering a 20% dropout rate)

NCT ID: NCT05829590 Not yet recruiting - Colonoscopy Clinical Trials

AI-assisted Colonoscopy Report System In Improving Reporting Quality

Start date: May 15, 2023
Phase: N/A
Study type: Interventional

In this study, the investigators proposed a prospective study about the effectiveness of speech and image recognition-based system in improving reporting quality during colonoscopy for colonoscopy report quality in endoscopists. The participants would be divided into two groups. For the collected colonoscopy videos, group A would record their observations with the assistance of the artificial intelligence system. The artificial intelligence assistant system can automatically capture bowel segment images and prompt abnormal lesions. Group B would complete the endoscopy report without special prompts. After a period of washout period, the two groups switched, that is, group A without AI assistance and group B with AI assistance to complete the colonoscopy report. Then, the completeness of the colonoscopy report, the completeness of capturing anatomical landmarks and detected lesions, the completeness of structured description, the accuracy of lesion reporting, the time for reporting and the satisfaction with the reporting system are compared with or without AI assistance.

NCT ID: NCT05734079 Not yet recruiting - Colonoscopy Clinical Trials

Impact of Digital Tools on the Quality of Bowel Preparation for Colonoscopy

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This is a single blinded randomized controlled study. The main question of this study is whether better preparation by making full use of digital tools can increase patient compliance with the preparation methods for colonoscopy, and as a result improve bowel preparation quality and colonoscopy outcomes in a cost-effective manner. Participants will randomly assigned to one of three colonoscopy preparation groups (i) a written hand out containing all information required for bowel preparation (standard care) (ii) standard care and in addition a video call with a professional nurse conducted via digital devices and a free software (Zoom video communication or What's app application) (iii) standard care and in addition to a video call as described above using an explanatory short video on bowel preparation (video film), streamed to the patient's mobile device or computer.

NCT ID: NCT05689242 Not yet recruiting - Colonoscopy Clinical Trials

Intravenous Nalbuphine Versus Intravenous Dexmedetomidine for Conscious Sedation in Patients Undergoing Colonoscopy

Start date: March 2023
Phase: Phase 4
Study type: Interventional

The aim of this study is to compare the sedative, analgesic effect and hemodynamic changes due to dexmedetomidine and nalbuphine during elective colonoscopy.

NCT ID: NCT05687045 Not yet recruiting - Colonoscopy Clinical Trials

High Flow Nasal Cannula in Patients Undergoing Colonoscopy

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

During colonoscopy, the insertion of the fiberscope and colon distension required to perform the examination may induce modifications to respiratory mechanics, respiratory effort and breathing pattern. High-flow nasal cannula (HFNC) therapy is a mixed air-oxygen supply system able to deliver heated humidified gas up to 60 L/min of flow rate, with an inspiratory oxygen fraction (FiO2) ranging from 21% to 100%. Increasing evidence supports the use of HFNC in several clinical conditions and settings. When compared to standard therapy (ST), HFNC results in enhanced gas exchange and improved comfort. No studies have yet assessed the benefits of HFNC versus ST during and after colonoscopy. The investigators designed this unblinded randomized controlled trial to assess whether HFNC, compared to ST, improves oxygenation at the end of the procedure (primary endpoint). Additional endpoints were: 1) the lowest peripheral saturation of oxygen (SpO2) and the number of oxygen desaturations; 2) the changes of end-expiratory lung impedance and tidal impedance assessed by Electrical Impedance Tomography (EIT); 3) the effects on diaphragm function assessed by ultrasound (DUS).

NCT ID: NCT05368792 Not yet recruiting - Colonoscopy Clinical Trials

Prospective Trial Of Osmolar Protocol Solution on Colonoscopy Outcomes and Patient Experience

POOPSCOPE
Start date: May 31, 2022
Phase: N/A
Study type: Interventional

Fasting is the current standard of care for colonoscopies. Recent changes to anesthesia guidelines have allowed for clear fluids to be provided up to 2 hours before procedures, including colonoscopies. This study will compare fasting to a 12.5% carbohydrate solution 2 hours before colonoscopy on patient-reported measures of discomfort, hydration, and colon visibility. The investigators hypothesize that the carbohydrate solution will improve patient-reported measures of discomfort, hydration, and colon visibility.

NCT ID: NCT05336773 Not yet recruiting - Ulcerative Colitis Clinical Trials

Ulcerative Colitis Mayo Score With Artificial Intelligence

Start date: April 2022
Phase:
Study type: Observational

This project will use deep learning to classify colonoscopy images of different severity of ulcerative colitis, so as to assist clinicians in the accurate diagnosis of ulcerative colitis.